Rybelsus is the first oral GLP-1 receptor agonist licensed in the UK, offering a tablet alternative to injectable diabetes treatments
What monitoring will be required regardless of the dosing approach chosen
These can include: Tingling in the arms or legs (paresthesia) Nausea, diarrhea, or stomach discomfort Changes in how food tastes Tiredness, drowsiness, or feeling dizzy Slower reaction time or trouble with memory and speech Fever, abdominal pain, or minor vision changes Rare but serious side effects Serious reactions are uncommon, but its important to recognize warning signs and act quickly: Kidney stones Topamax increases the risk of kidney stones
Entre los diferentes efectos del GLP-1 que regulan la homeostasis de la glucosa, se han incluido la secrecin de insulina dependiente de la glucosa a partir de las clulas beta-pancreticas, la disminucin de la concentracin plasmtica de glucagn y el retraso del vaciamiento gstrico
GLP-1RAs also have beneficial effects on pain-related behaviors
